Xyl01 0002 01
Xylocaine Injection, Solution
Product Images NDC 63323-488
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 63323-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Xyl01 0002 02
Xyl01 0002 03
Xyl01 0002 04
This text is a description of a pharmaceutical product, specifically an injectable solution of lidocaine HCI. The text provides information about the product's NDC code, sterility, ability to be resterilized, recommended storage conditions, concentration, and approved uses. The product is indicated for infiltration and nerve blocks but should not be used for caudal or epidural applications. The product comes in a 50 mL multi-dose vial and is manufactured by Dorotech, a company based in the USA.*
Xyl01 0002 05
This is a package of Lidocaine HCI Injection with 250 mg/50 mL solution for nerve blocks and filtration. It contains 25 multiple-dose vials, each with 50 mL sterile and pyrogen-free solution that must be stored at a temperature between 20 to 25°C. The package insert must be consulted for dosage information and full prescribing details. This product is not intended for caudal or epidural use and should not be used if the solution is discolored or contains precipitate. It can be sterilized through autoclaving. The NDC number is 63323-484-57, and it is to be sold only as an unbroken package.*
Xyl01 0002 06
This is a packaging description of Lidocaine HCI Injection, USP, containing 200 mg per 20 mL solution. It comes in a sterile, nonpyrogenic, and multiple dosage vial that can be resterilized by autoclaving. It should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). This medication is intended only for infiltration and nerve block and should not be used for caudal or epidural use. If the solution is discolored or contains a precipitate, do not use it. This product is manufactured by Fresenius Kabi, and the NDC is 63323-485-01.*
Xyl01 0002 07
NDC 63323-485-27 480527 is a sterile, nonpyrogenic solution of Lidocaine HCI Injection, USP which is not to be used if the solution is discolored or contains a precipitate. It contains Lidocaine HCI 10mg, sodium chloride 7mg, Methylparaben 1mg, and hydrochloric acid to adjust pH. It is meant for Infiltration and Nerve Block and should not be used for Caudal or Epidural. The solution comes in 25 multiple-dose vials of 20 mL each, which can be resterilized by autoclaving. It is available only as an unbroken package and should be stored at 20° to 25°C (68° to 77°F) or room temperature. For dosage and prescribing information, consult the package insert. This product is trademarked by Fresenius Kabi USA, LLC and it is based in Lake Zurich, IL 60047.*
Xyl01 0002 08
This is a product description for Xylocaine MPF, which is an injection containing lidocaine HCI and epinephrine, and is intended for use in infiltration and nerve block, including caudal and epidural use. It is a single-dose vial that contains 300 mg per 30 mL (10 mg per mL) and is methylparaben free. It should not be autoclaved as it contains epinephrine, and should not be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate. Unused portions should be discarded and it should be protected from light. It is manufactured by Fresenius Kabi and should be stored in a controlled room temperature environment until use.*
Xyl01 0002 09
Xylocaine-MPF is a sterile, nonpyrogenic solution administered by injection used for infiltration and nerve block, including caudal and epidural use. It contains Lidocaine HCI, epinephrine, citric acid, sodium chloride, and sodium metabisuffite, with each mL consisting of Lidocaine HCI 10mg and Epinephrine 0.005mg. The solution comes in 25 single-dose vials of 30mL, and it is methylparaben free. The package insert should be consulted for dosage and complete prescribing information. The injection should not be autoclaved and should not be used if it contains a precipitate or has a color that is pinkish or darker than slightly yellow. Unused portions should be discarded, and the solution should be kept protected from light and stored in the carton until time of use. It should be stored at a temperature of 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. This solution is a trademark of Fresenius Kabi USA, LLC.*
Xyl01 0002 10
This is a description of a medication called Xylocaine MPF which is an injection of lidocaine HCI and epinephrine solution. It comes in a single dose vial of 30 mL and is indicated for infiltration and nerve block, including caudal and epidural use. The solution is methylparaben free and contains 450 mg per 30 mL, with 15 mg per mL concentration. It should not be autoclaved due to the presence of epinephrine. The injection should not be used if it has a pinkish color or a precipitate. The unused portion should be discarded, the solution should be protected from light, and stored at 20° to 25°C (68° to 77°F).*
Xyl01 0002 11
Xylocaine-MPF is an injection used for infiltration and nerve block, including caudal and epidural use. It is methylparaben free and comes in 25 single dose vials of 30mL. Each mL contains Lidocaine HCI 15 mg, Epinephrine (as the bitartrate) 0.005 mg, Citric acid 0.2 mg, Sodium chloride 65mg, Sodium metabisulfite 0.5mg with sodium hydroxide and/or hydrochloric acid to adjust pH approx. 4.5 (3.3 10 5.5). It should not be autoclaved as it contains epinephrine and should not be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate. It is to be sold only as an unbroken package, and unused portions must be discarded. It should be protected from light and stored in the carton until the time of use at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. The manufacturer is Fresenius Kabi USA, LLC.*
Xyl01 0002 12
Xylocaine with Epinephrine 1:100,000 IR is a medication used for infiltration and nerve block injection, with a dosage of 400 mg per 20 mL. This multiple dose vial is sterile and nonpyrogenic, and should be protected from light. It is not intended for use in caudal or epidural procedures. If the injection is pinkish or darker than slightly yellow, or contains a precipitate, it should not be used. The medication is to be stored at 20° to 25°C (68° to 77°F) until the contents have been used, in a carton provided. The product is manufactured by Fresenius Kabi and prescription-only.*
Xyl01 0002 13
Xylocaine® is a medication used for infiltration and nerve block, supplied in sterile, non-pyrogenic 20 mL vials containing 2% Lidocaine HCl and epinephrine (B with Epinephrine 1:100,000). It is not for caudal or epidural use and should not be autoclaved due to epinephrine content. Xylocaine® should be stored at 20° to 25°C (68° to 77°F), protected from light, and not to be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate. It is filled under nitrogen and each mL contains Lidocaine HCI 20mg, Epinephrine (as the bitartrate) 001 mg, citric acid 02mg, sodium chloride 6mg, sodium metabisulfite 05mg, and methylparaben 1mg. Xylocaine® is manufactured and distributed by Fresenius Kabi USA, LLC. For dosage and full prescribing information, refer to the package insert.*
Xyl01 0002 14
This is a medication with the brand name "Xylocaine." It is a 2% (20mg/mL) solution of lidocaine hydrochloride that is sterile, non-pyrogenic, and intended for infiltration and nerve block use. It comes in a 10mL multiple-dose vial that can be re-sterilized by autoclaving. This medication is NOT to be used for caudal or epidural use. It should not be used if the solution is discolored or contains a precipitate. This medication should be stored at USP-controlled room temperature between 20 and 25°C (68° to 77°F). The manufacturer is Fresenius Kabi, located in Lake Zurich, IL.*
Xyl01 0002 15
Xylocaine® (lidocaine HC1 Injection, USP) is available in 10ml multiple dose vials with 200mg lidocaine HC1 (2% w/v) per 10ml. It is sterile, non-pyrogenic and is intended for infiltration and nerve block only. It is not recommended for caudal or epidural use. The pH is adjusted to approximately 6.5 to 7.0 with sodium hydroxide and/or hydrochloric acid. It can be autoclaved for resterilization while the dosage and full prescribing information can be found in the package insert. It should be stored at 20° to 25°C (68° to 77°F) according to USP Controlled Room Temperature. If the solution is discolored or if it contains any precipitate, it should not be used. All trademarks are the property of Fresenius Kabi USA, LLC.*
Xyl01 0002 16
Xylocaine-MPF is a solution for infiltration and nerve block, including caudal and epidural use. It is a single-dose vial that should be discarded if there is any color other than slightly yellow or has precipitate. Xylocaine-MPF contains lidocaine HCI and epinephrine and is packaged in a 20 mL vial. It is methylparaben-free and should be stored in the carton and protected from light. The solution must not be autoclaved and is only for Rx use. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL, and the lot number is 402454.*
Xyl01 0002 17
Xyl01 0002 18
This is a description of lidocaine HCI injection, which is a sterile, nonpyrogenic solution contained in a 50 mL single-dose vial. Each vial contains 250 mg per 50 mL (5mg per mL) of lidocaine HCI. The injection is used for infiltration and intravenous regional anesthesia. The vial can be resterilized by autoclaving but should not be used if the solution is discolored or contains a precipitate. It is recommended to store the vial between 20°C to 25°C. This product is free of methylparaben.*
Xyl01 0002 19
Xylocaine-MPF is a lidocaine HCI injection, USP that is intended for infiltration and intravenous regional anesthesia. It is methylparaben-free, sterile, nonpyrogenic, and can be resterilized by autoclaving. The package contains 25 single dose vials of 50 mL and should be stored at 20° to 25°C (68° to 77°F). Each mL contains Lidocaine HCI 5mg and Sodium chloride 8mg with Sodium hydroxide and/or hydrochloric acid to adjust pH approx. 6.5(5.0t07.0). A package insert is included for dosage and full prescribing information. Unused portions should be discarded, and the vial should not be used if the solution is discolored or contains a precipitate. It is a product of Fresenius Kabi USA LLC.*
Xyl01 0002 20
NDC 63323-492-09 491257 Sterile, nonpyrogenic. GBS can be resterilized by autoclaving. Xylocaine-MPF (lidocaine HC injection, USP) is an injectable solution that contains 50 mg per 5 mL (10 mg per mL) and is stored at 20°C to 25°C (68°F to 77°F) as per USP Controlled room temperature regulations. It is used for infiltration and nerve block, including caudal and epidural use. Fresenius Kabi manufactures the product and packages it in a 5 mL single-dose vial, which is available only with a prescription. Visit www.fresenius-kabi.com/us for more information.*
Xyl01 0002 21
Xylocaine® -MPF is a lidocaine HCI injection used for infiltration and nerve block, including caudal and epidural use. This is a methylparaben-free, sterile, nonpyrogenic solution with 10mg of lidocaine HCI and 7mg of sodium chloride per mL. It can be resterilized by autoclaving and comes in a package of 25 single-dose vials, 5 mL each. Follow the package insert for the correct dosage and full prescribing information. Store at 20°to 25°C (68°to 77°F). It should only be sold as an unbroken package. If the solution is discolored or contains a precipitate, do not use, and discard any unused portion. All trademarks belong to Fresenius Kabi USA, LLC, located in Lake Zurich, IL.*
Xyl01 0002 22
Xylocaine-MPF is a lidocaine HCI injection used for infiltration and nerve block, including caudal and epidural use. It comes in a 2 mL single-dose vial that is methylparaben-free. This product is manufactured by Fresenius Kabi and has an NDC of 63323-495-09. Unfortunately, no information is available about the LOT/EXP.*
Xyl01 0002 23
The given text provides information about Xylocaine-MPF, which is an injection of lidocaine HCI used for infiltration and nerve block, including for caudal and epidural use. The injection comes in single-dose vials, contains 0.4mg per 2ml, and is methylparaben-free. The manufacturer is Fresenius Kabi. NDC, a unique universal product identifier for drugs in the United States, is also provided.*
Xyl01 0002 24
This is a description of a medication with the National Drug Code (NDC) 63323-495-04. The medication is sterile, nonpyrogenic and contains lidocaine HC Injection, USP. It is a 2% solution with 100mg per Sml. The medication is to be stored between 20° to 25°C (68° to 77°F). The medication is methylparaben free and is available in a 5 mL single dose vial. It can be resterilized by autoclaving. It should not be used if the solution is discolored or there is a precipitate. It is suitable for use in infiltration and nerve block procedures, including caudal and epidural use.*
Xyl01 0002 25
Xylocaine-MPF is a local anesthetic injection containing Lidocaine HCI, which is used for infiltration and nerve block, including caudal and epidural use. It is methylparaben-free and is available in the form of 25 single-dose vials, each containing 5ml of the solution. Each mL of the solution contains Lidocaine HCI 20mg, Sodium chloride 6mg, and Sodium hydroxide and/or hydrochloric acid to adjust pH approx. 6.5 (5.0-7.0). The injection can be resterilized by autoclaving, and unused portions should be discarded. The injection must not be used if the solution is discolored or contains precipitate. It is sold only as an unbroken package and must be stored at 20°C to 25°C. The dosage and full prescribing information can be found in the package insert.*
Xyl01 0002 26
This is a description of Xylocaine, a medication that contains lidocaine HCI and epinephrine injection. It is intended for infiltration and nerve block and comes in a 50mL multiple dose vial that should be protected from light and stored between 20-25°C. This medication should not be used for caudal or epidural use, if its color is pinkish or darker than slightly yellow, or if it contains a precipitate. Additionally, the medication cannot be autoclaved because it contains epinephrine. The manufacturer of Xylocaine is Fresenius Kabi and it is available via prescription only.*
Xyl01 0002 27
This text contains information about a drug called Xylocaine, which is an injection used for Infiltration and Nerve Block that contains Lidocaine HCI and Epinephrine with detailed prescription information, dosage quantity, storage instructions, and manufacturing details. The drug is not for Caudal or Epidural use and is available in 25 multiple dose vials of 50ml to be sold as an unbroken package. The injection should not be used if its color is pinkish, darker than slightly yellow or it contains a precipitate, and protective measures against light should be taken while storing it. The manufacturer is Fresenius Kabi USA, LLC.*
Xyl01 0002 28
Xylocaine is a sterile solution containing lidocaine HCI and Epinephrine injection. It is packaged in a 10 mL multiple-dose vial and used for Infiltration and Nerve Block, except for Caudal or Epidural Use. The solution should not be autoclaved because it contains epinephrine. The solution should not be used if its color appears pinkish or darker than slightly yellow or if it contains a precipitate. The solution should be protected from light and stored in the carton until the contents have been used. It should be stored at 20° to 25°C (68° to 77°F) according to USP Controlled Room Temperature guidelines. The manufacturer is Fresenius Kabi based in Lake Zurich, IL. LOT/EXP information is also available.*
Xyl01 0002 29
Xylocaine® (lidocaine HCI and epinephrine Injection, USP) is a solution used for infiltration and nerve block purposes. It contains Lidocaine HCI, Epinephrine, citric acid, sodium chloride, sodium metabisulfite, and methylparaben. The solution comes in 25 multiple dose vials, 10 mL each. It is sterile, nonpyrogenic, and not for caudal or epidural use. The injection should not be used if discolored or containing a precipitate. It needs to be protected from light, and the contents must be used before expiring. The package insert should be consulted for dosage and full prescribing information. The solution should not be autoclaved and should be stored in the carton at 20° to 25°C (68° to 77°F).*
Xyl01 0002 30
This is a product information label for Xylocaine-MPF, which is an injection used for infiltration and nerve block, including caudal and epidural cases. It contains 20 mg of lidocaine HCI per 2 mL of solution, with a concentration of 1% per milliliter. The injection comes in a single dose vial with a lot/exp number, and is methylparaben free. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL.*
Xyl01 0002 31
The text describes a medication called Xylocaine-MPF in the form of an injection. It contains lidocaine HCI and comes in single-dose vials that are intended for infiltration and nerve block, including caudal and epidural use. The medication is methylparaben-free and requires a prescription. The manufacturer is Fresenius Kabi.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
